NRD
VCYT icon

Nebula Research & Development’s Veracyte VCYT Stock Holding History

Nebula Research & Development’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-43,451
Closed -$1.17M – 840
2025
Q2 		$1.17M Sell
43,451
-4,736
-10% -$137K 0.1% 344
2025
Q1 		$1.43M Buy
48,187
+2,951
+7% +$112K 0.13% 260
2024
Q4 		$1.79M Sell
45,236
-1,283
-3% -$48.6K 0.21% 130
2024
Q3 		$1.58M Buy
+46,519
New +$1.31M 0.19% 147

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nebula Research & Development's VCYT Position: Q3 2025 in Review

Nebula Research & Development sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 43,451 shares — an estimated $1.17M sold.

Nebula Research & Development first reported a position in VCYT in Q3 2024 and held it in 4 quarters. The position peaked at $1.79M in Q4 2024. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Nebula Research & Development reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 43,451 Veracyte shares in Q3 2025, an estimated $1.17M.
  • Nebula Research & Development first reported a position in Veracyte in Q3 2024 and held it in 4 quarters.
  • Nebula Research & Development's Veracyte position peaked at $1.79M in Q4 2024.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.